Index of artpub/2016/pmc_27190631/

Brown, Sarah
The MUK five protocol : a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma
2016
https://ddd.uab.cat/record/185883
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Brown,_Sarah2022-06-29 13:31 13  
[ ]2=The_MUK_five_protocol__a_phase_II_randomised,...2022-06-29 13:31 276  
[ ]3=20162022-06-29 13:31 5  
[ ]4=1858832022-06-29 13:31 34  
[TXT]pmc_27190631.dirinfo2024-10-02 04:56 341  
[ ]pmc_27190631.du2024-10-02 04:56 34  
[TXT]pmc_27190631.dupdirs2024-10-02 04:56 0  
[TXT]pmc_27190631.dupfiles2024-10-02 04:56 0  
[TXT]pmc_27190631.errors2024-10-02 04:56 0  
[IMG]pmc_27190631.gif2024-10-02 04:56 49K 
[IMG]pmc_27190631.ico2024-10-02 04:56 12K 
[TXT]pmc_27190631.info2024-10-02 04:56 56K 
[TXT]pmc_27190631.md52024-10-02 04:56 51  
[ ]pmc_27190631.pdf2024-10-02 04:56 809K 
[TXT]pmc_27190631.sha12024-10-02 04:56 59  
[TXT]pmc_27190631.sha2562024-10-02 04:56 83  
[TXT]pmc_27190631.stats2024-10-02 04:56 293  
[TXT]pmc_27190631.txt2024-10-02 04:56 57K